The battle of the bulge has been a big, fat failure for U.S. drug makers. But that hasn't stopped them from trying.

The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the United States.

The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with industry released by the agency on Friday.